Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Synairgen has announce that recruitment of 100 hospitalised patients in its clinical trial of SNG001 in COVID-19 patients has now been completed.
read more
Wednesday, November 07, 2018
Symphogen has selected TransPerfect’s Trial Interactive eTMF and supporting TMF services to centralize and streamline operations for current and future studies.
read more
Wednesday, October 08, 2025
Symeres has appointed Gabriella Gentile as Chief Operating Officer (COO). This strategic addition to the executive team supports Symeres’ transatlantic growth ambitions, building upon its strong foundations in existing and novel modalities.
read more
Wednesday, January 14, 2026
Symeres announced the appointment of Jurgen Berendsen as Chief Financial Officer (CFO), marking a significant return to the company after a successful tenure as Senior Group Controller.
read more
Wednesday, September 10, 2025
Symeres, a global Contract Research, Development and Manufacturing Organization (CRDMO), announced the acquisition of DGr Pharma, a drug development-focused consultancy, to expand its integrated early-stage drug development services and accelerate ...
read more
Tuesday, November 21, 2017
Symcel has secured a Horizon 2020 funding to support the company’s evaluation of improved combination testing of antibiotics against extensively drug-resistant bacteria in sepsis patients.
read more
Wednesday, December 21, 2016
Symcel, the provider of the cell-based assay tool for real-time cellular bioenergetic measurements, calScreener™, has partnered with Colzyx to test 25 different new collagen VI derived antimicrobial peptides – analyzing their capability to kill ...
read more
Monday, February 12, 2018
Symcel is expanding to bring its patented technology to the clinical antimicrobial susceptibility testing (AST) markets.
read more
Wednesday, March 21, 2018
Symbiotix Biotherapies has entered into a license agreement with Harvard University.
read more
Symbiosis has signed a supply agreement with AstraZeneca for sterile manufacture of the COVID-19 recombinant adenovirus vaccine known as AZD1222.
read more
Symbiosis has successfully completed a scheduled inspection by the UK Government regulator, the MHRA.
read more
Friday, September 28, 2018
Symbiosis Pharmaceutical Services has reported FDA approval for its viral vector manufacturing fill/finish process at its biologics manufacturing facility located in Scotland, UK.
read more
Symbiosis Pharmaceutical Services has secured £1million of finance from Allied Irish Bank (GB) to support its 2020 growth strategy.
read more
Symbiosis Pharmaceutical Services has appointed Joanne Anderson as chief commercial officer, strengthening the leadership team at the Stirling, UK–based contract development and manufacturing organization (CDMO).
read more
Tuesday, December 17, 2019
Contract Manufacturing Organization (CMO) Symbiosis Pharmaceutical Services has expanded its sterile biologics manufacturing facility in Scotland, UK by 25%.
read more